Skip Nav Destination
Issues
1 February 2021
-
Cover Image
Cover Image
The cover shows fluorescence in situ hybridization of the U6 small nuclear RNA in normal respiratory tract pseudostratified epithelial cells (pink). U6 is a key RNA spliceosome complex component often used as a reference gene for miRNA measurements. The green signal is autofluorescence of connective tissue matrix in the submucosa. miRNA classification of aerodigestive epithelial tumors can be used clinically and as a means to understand cancer pathophysiology. For details, see the article by Holt and colleagues on page 831 of this issue. (Photomicrograph by Phillip Clapp and Scott Randell; used with permission.) - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Reviews
Clinical Trials: Targeted Therapy
Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641)
Xinghao Ai; Jiuwei Cui; Jiexia Zhang; Rongrong Chen; Wen Lin; Congying Xie; Anwen Liu; Junping Zhang; Weihua Yang; Xiaohua Hu; Xiaohua Hu; Qiong Zhao; Chuangzhou Rao; Yuan-Sheng Zang; Ruiling Ning; Pansong Li; Lianpeng Chang; Xin Yi; Shun Lu
Clinical Trials: Immunotherapy
Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib
Dae-Won Lee; Eun Ju Cho; Jeong-Hoon Lee; Su Jong Yu; Yoon Jun Kim; Jung-Hwan Yoon; Tae-Yong Kim; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Youngeun Lee; Haeryoung Kim; Kyung-Hun Lee
Precision Medicine and Imaging
Author Choice
A Prospective Validation and Observer Performance Study of a Deep Learning Algorithm for Pathologic Diagnosis of Gastric Tumors in Endoscopic Biopsies
Jeonghyuk Park; Bo Gun Jang; Yeong Won Kim; Hyunho Park; Baek-hui Kim; Myeung Ju Kim; Hyungsuk Ko; Jae Moon Gwak; Eun Ji Lee; Yul Ri Chung; Kyungdoc Kim; Jae Kyung Myung; Jeong Hwan Park; Dong Youl Choi; Chang Won Jung; Bong-Hee Park; Kyu-Hwan Jung; Dong-Il Kim
Translational Cancer Mechanisms and Therapy
Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg; Henri A.J. Puttonen; Martin Sjöström; Erik Holmberg; S. Laura Chang; Felix Y. Feng; Corey Speers; Lori J. Pierce; Dan Lundstedt; Fredrika Killander; Emma Niméus; Anikó Kovács; Per Karlsson
Author Choice
Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer
Diana C. DeLucia; Thomas M. Cardillo; Lisa Ang; Mark P. Labrecque; Ailin Zhang; James E. Hopkins; Navonil De Sarkar; Ilsa Coleman; Rui M. Gil da Costa; Eva Corey; Lawrence D. True; Michael C. Haffner; Michael T. Schweizer; Colm Morrissey; Peter S. Nelson; John K. Lee
Author Choice
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice
Pierre Montay-Gruel; Munjal M. Acharya; Patrik Gonçalves Jorge; Benoît Petit; Ioannis G. Petridis; Philippe Fuchs; Ron Leavitt; Kristoffer Petersson; Maude Gondré; Jonathan Ollivier; Raphael Moeckli; François Bochud; Claude Bailat; Jean Bourhis; Jean-François Germond; Charles L. Limoli; Marie-Catherine Vozenin
MET Exon 14–altered Lung Cancers and MET Inhibitor Resistance
Robin Guo; Michael Offin; A. Rose Brannon; Jason Chang; Andrew Chow; Lukas Delasos; Jeffrey Girshman; Olivia Wilkins; Caroline G. McCarthy; Alex Makhnin; Christina Falcon; Kerry Scott; Yuan Tian; Fabiola Cecchi; Todd Hembrough; Deepu Alex; Ronglai Shen; Ryma Benayed; Bob T. Li; Charles M. Rudin; Mark G. Kris; Maria E. Arcila; Natasha Rekhtman; Paul Paik; Ahmet Zehir; Alexander Drilon
Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
Denis M. Collins; Stephen F. Madden; Nicola Gaynor; Dalal AlSultan; Marion Le Gal; Alex J. Eustace; Kathy A. Gately; Clare Hughes; Anthony M. Davies; Thamir Mahgoub; Jo Ballot; Sinead Toomey; Darran P. O'Connor; William M. Gallagher; Frankie A. Holmes; Virginia Espina; Lance Liotta; Bryan T. Hennessy; Kenneth J. O'Byrne; Max Hasmann; Birgit Bossenmaier; Norma O'Donovan; John Crown
Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy
Zachary J. Walker; Beau M. Idler; Lorraine N. Davis; Brett M. Stevens; Michael J. VanWyngarden; Denis Ohlstrom; Shelby C. Bearrows; Andrew Hammes; Clayton A. Smith; Craig T. Jordan; Tomer M. Mark; Peter A. Forsberg; Daniel W. Sherbenou
Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia
Arnon Nagler; Myriam Labopin; Bhagirathbhai Dholaria; Emanuele Angelucci; Boris Afanasyev; Jan J. Cornelissen; Simona Sica; Ellen Meijer; Fabio Ciceri; Gwendolyn Van Gorkom; Nicolaus Kröger; Hans Martin; Pietro Pioltelli; Antonio Risitano; Jonathan Canaani; Bipin N. Savani; Jaime Sanz; Mohamad Mohty
Author Choice
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Renata Ferrarotto; Yoshitsugu Mitani; Daniel J. McGrail; Kaiyi Li; Tatiana V. Karpinets; Diana Bell; Steven J. Frank; Xingzhi Song; Michael E. Kupferman; Bin Liu; J. Jack Lee; Bonnie S. Glisson; Jianhua Zhang; Jon C. Aster; Shiaw-Yih Lin; P. Andrew Futreal; John V. Heymach; Adel K. El-Naggar
NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes
Anju Singh; Anneleen Daemen; Dorothee Nickles; Sang-Min Jeon; Oded Foreman; Kuladeep Sudini; Florian Gnad; Stephane Lajoie; Naina Gour; Wayne Mitzner; Samit Chatterjee; Eun-Ji Choi; Buvana Ravishankar; Amy Rappaport; Namrata Patil; Mark McCleland; Leisa Johnson; George Acquaah-Mensah; Edward Gabrielson; Shyam Biswal; Georgia Hatzivassiliou
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds